In ER-positive, “immune-cold” breast cancers, letrozole attacks against estrogen regulation causerapid recruiting of dense immune cell infiltration and copious cytokine secretion, upregulating aromatase expression and estrogen synthesis. Here, CYP19A1 is linked to breast cancer.